GSA Capital Partners’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-23,006
| Closed | -$311K | – | 1258 |
|
|
2020
Q1 | $311K | Buy |
+23,006
| New | +$311K | 0.08% | 460 |
|
|
2019
Q4 | – | Sell |
-12,309
| Closed | -$237K | – | 1825 |
|
|
2019
Q3 | $237K | Sell |
12,309
-11,900
| -49% | -$229K | 0.03% | 1082 |
|
|
2019
Q2 | $715K | Buy |
+24,209
| New | +$715K | 0.08% | 439 |
|
|
2018
Q4 | – | Sell |
-6,000
| Closed | -$369K | – | 1858 |
|
|
2018
Q3 | $369K | Buy |
+6,000
| New | +$369K | 0.02% | 1225 |
|
|
2018
Q1 | – | Sell |
-16,400
| Closed | -$980K | – | 1893 |
|
|
2017
Q4 | $980K | Buy |
16,400
+9,956
| +155% | +$595K | 0.06% | 605 |
|
|
2017
Q3 | $313K | Buy |
6,444
+1,538
| +31% | +$74.7K | 0.02% | 1217 |
|
|
2017
Q2 | $258K | Buy |
+4,906
| New | +$258K | 0.02% | 1368 |
|
|
2016
Q3 | – | Sell |
-12,437
| Closed | -$219K | – | 2033 |
|
|
2016
Q2 | $219K | Buy |
+12,437
| New | +$219K | 0.01% | 1529 |
|
|
2015
Q4 | – | Sell |
-41,248
| Closed | -$732K | – | 2021 |
|
|
2015
Q3 | $732K | Buy |
+41,248
| New | +$732K | 0.04% | 874 |
|